Financial Health Report: Staar Surgical Co (STAA)’s Ratios Tell a Tale

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

Staar Surgical Co (NASDAQ: STAA) closed the day trading at $17.61 up 3.31% from the previous closing price of $17.05. In other words, the price has increased by $3.31 from its previous closing price. On the day, 0.78 million shares were traded. STAA stock price reached its highest trading level at $17.97 during the session, while it also had its lowest trading level at $17.088.

Ratios:

For a better understanding of STAA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.62 and its Current Ratio is at 5.23. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.

On February 12, 2025, Mizuho Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $45 to $17.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’25 when BROADWOOD PARTNERS, L.P. bought 27,953 shares for $17.24 per share. The transaction valued at 481,849 led to the insider holds 11,981,151 shares of the business.

BROADWOOD PARTNERS, L.P. bought 259,316 shares of STAA for $4,420,106 on Feb 27 ’25. The 10% Owner now owns 11,548,753 shares after completing the transaction at $17.05 per share. On Mar 03 ’25, another insider, BROADWOOD PARTNERS, L.P., who serves as the 10% Owner of the company, bought 249,503 shares for $16.64 each. As a result, the insider paid 4,151,214 and bolstered with 11,953,198 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STAA now has a Market Capitalization of 868866880 and an Enterprise Value of 676833600. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.77 while its Price-to-Book (P/B) ratio in mrq is 2.19. Its current Enterprise Value per Revenue stands at 2.156 whereas that against EBITDA is -124.008.

Stock Price History:

The Beta on a monthly basis for STAA is 0.77, which has changed by -0.5434275 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, STAA has reached a high of $52.68, while it has fallen to a 52-week low of $13.50. The 50-Day Moving Average of the stock is -14.12%, while the 200-Day Moving Average is calculated to be -42.72%.

Shares Statistics:

Over the past 3-months, STAA traded about 1.02M shares per day on average, while over the past 10 days, STAA traded about 1084680 shares per day. A total of 49.29M shares are outstanding, with a floating share count of 48.99M. Insiders hold about 0.67% of the company’s shares, while institutions hold 102.21% stake in the company. Shares short for STAA as of 1740700800 were 4569673 with a Short Ratio of 4.49, compared to 1738281600 on 3944156. Therefore, it implies a Short% of Shares Outstanding of 4569673 and a Short% of Float of 18.44.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Earnings Estimates

Currently, 9.0 analysts are dedicated to thoroughly evaluating and rating the performance of Staar Surgical Co (STAA) in the stock market.The consensus estimate for the next quarter is -$0.59, with high estimates of -$0.5 and low estimates of -$0.67.

Analysts are recommending an EPS of between -$0.61 and -$1.15 for the fiscal current year, implying an average EPS of -$0.87. EPS for the following year is $0.13, with 9.0 analysts recommending between $0.82 and -$0.84.

Revenue Estimates

11 analysts predict $40.33M in revenue for the current quarter. It ranges from a high estimate of $41.55M to a low estimate of $39.74M. As of the current estimate, Staar Surgical Co’s year-ago sales were $77.36MFor the next quarter, 11 analysts are estimating revenue of $41.1M. There is a high estimate of $45M for the next quarter, whereas the lowest estimate is $39.24M.

A total of 13 analysts have provided revenue estimates for STAA’s current fiscal year. The highest revenue estimate was $281M, while the lowest revenue estimate was $242.1M, resulting in an average revenue estimate of $260.75M. In the same quarter a year ago, actual revenue was $313.9MBased on 13 analysts’ estimates, the company’s revenue will be $328.25M in the next fiscal year. The high estimate is $394.03M and the low estimate is $272.47M.

Most Popular